Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues

Journal of Steroid Biochemistry and Molecular Biology

Volumn 72, Issue 1-2, 2000, Pages 23-27

  Chetrite, G S ^a   Cortes Prieto, J ^b   Philippe, J C ^a   Wright, F ^c   Pasqualini, J R ^a  

^a Hormones and Cancer Research Unit   (France)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; ESTRADIOL; ESTRADIOL SULFATE; ESTROGEN; ESTRONE; ESTRONE SULFATASE; ESTRONE SULFATE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; POSTMENOPAUSE; TISSUE LEVEL;

AGED; AROMATASE; BREAST; BREAST NEOPLASMS; ESTRADIOL; ESTROGENS; ESTROGENS, CONJUGATED (USP); ESTRONE; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; SULFATASES;

EID: 0034016224     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(00)00040-6     Document Type: Article

References (26)

1. Kirschner M.A. The role of hormones in the development of human breast cancer. Breast Cancer 3: Advances in Research and Treatment, Current Topics. 1979;199-226 Plenum, New York.
2. Osborne C.K, Hobbs K., Clark G.M. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res. 45:1985;584-590.
3. Henderson B.E., Ross R., Bernstein L. Estrogens as a cause of human cancer, The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res. 48:1988;246-253.
4. Abul-Hajj Y.J., Iverson R., Kiang D.T. Aromatization of androgens by human breast cancer. Steroids. 33:1978;205-222.
5. Lipton A., Santner S., Santen R.J., Harvey H.A., Feil P.D., White-Hershey D., Bartholomew M.J., Antle C.E. Aromatase activity in primary and metastatic human breast cancer. Cancer. 59:1987;779-782.
6. Perel E., Daniilescu D., Kharlip L., Blankenstein M., Killenger D.W. Steroid modulation of aromatase activity in human cultured breast carcinoma cells. J. Steroid Biochem. 29:1988;393-399.
7. T.L. Dao, C. Hayes, P.R. Libby, Steroid sulfatase activities in human breast tumors. Proc. Soc. Experim. Biol. & Med. 1974, 381-384.
8. Vignon F., Terqui M., Westley B., Derocq D., Rochefort H. Effects of plasma estrogen sulfates in mammary cancer cells. Endocrinology. 106:1980;1079-1086.
9. Tseng L., Mazella J., Lee L.Y., Stone M.L. Estrogen sulfatase and estrogen sulfotransferase in human primary mammary carcinoma. J. Steroid Biochem. 19:1983;1413-1417.
10. Pasqualini J.R., Gelly C., Lecerf L. Biological effects and morphological responses to estriol, estriol-3-sulfate, estriol-17-sulfate and tamoxifen in a tamoxifen-resistant cell line (R-27) derived from MCF-7 human breast cancer cells. Eur. J. Cancer Clin. Oncol. 22:1986;1495-1501.
11. Pasqualini J.R., Gelly C., Nguyen B.-L., Vella C. Importance of estrogen sulfates in breast cancer. J. Steroid Biochem. 34:1989;155-163.
12. Pasqualini J.R., Schatz B., Varin C., Nguyen B.-L. Recent data on estrogen sulfatases and sulfotransferases activities in human breast cancer. J. Steroid Biochem. Molec. Biol. 41:1992;323-329.
13. Pollow K., Boquoi E., Baumann J., Schmidt-Gollwitzer M., Pollow B. Comparison of the in vitro conversion of estradiol-17β to estrone of normal and neoplastic human breast tissue. Molec. Cell. Endocr. 6:1977;333-348.
14. Abul-Hajj Y.J. Relationship between estrogen receptors, 17β-hydroxysteroid dehydrogenase and estrogen content in human breast cancer. Steroids. 34:1979;217-225.
15. Vermeulen A., Deslypere J.P., Paridaens R., Leclercq G., Roy F., Heuson J.C. Aromatase, 17β-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women. Eur. J. Cancer Clin. Oncol. 22:1986;515-525.
16. Nguyen B.-L., Chetrite G., Pasqualini J.R. Transformation of estrone and estradiol in hormone-dependent and hormone-independent human breast cancer cells. Effects of the anti-estrogen ICI 164 384, danazol, and promegestone (R-5020). Breast Cancer Res. Treat. 34:1995;139-146.
17. Santner S.J., Feil P.D., Santen R.J. In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway. J. Clin. Endocr. Metab. 59:1984;29-33.
18. Pasqualini J.R., Chetrite G., Blacker C., Feinstein M.-C., Delalonde L., Talbi M., Maloche C. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. J. Clin. Endocr. Metab. 81:1996;1460-1464.
19. 3H]-estradiol. J. Endocr. 89:1981;71-77.
20. Pasqualini J.R., Cornier E., Grenier J., Vella C., Schatz B., Netter A. Effect of Decapeptyl, an agonistic analog of gonadotropin-releasing hormone on estrogens, estrogen sulfates, and progesterone receptors in leiomyoma and myometrium. Fert. Steril. 53:1990;1012-1017.
21. MacIndoe J.H. The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells. Endocrinology. 123:1988;1281-1287.
22. Bearden J.C. Jr. Quantitation of submicrogram quantities of protein by an improved protein-dye binding assay. Biochim. Biophys. Acta. 533:1978;525-531.
23. Miller W.R., Forrest A.P.M., Hamilton T. Steroid metabolism by human breast and rat mammary carcinomata. Steroids. 23:1974;379-395.
24. Naitoh K., Honjo H., Yamamoto T., Urabe M., Ogino Y., Yasamura T., Nambara T. Estrone sulfate and sulfatase activity in human breast cancer and endometrial cancer. J. Steroid Biochem. 33:1989;1049-1054.
25. Söderqvist G., Olsson H., Wilking N., von Schoultz B., Carlström K. Metabolism of estrone sulfate by normal breast tissue: influence of menopausal status and oral contraceptives. J. Steroid Biochem. Molec. Biol. 48:1994;221-224.
26. Utsumi T., Yoshimura N., Takeuchi S., Ando J., Maruta M., Maeda K., Harada N. Steroid sulfatase expression is an independent predictor of recurrence in human breast cancer. Cancer Res. 59:1999;377-381.